Researcher profile

Aiyi Liu

Aiyi Liu contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Applications math.ST Methodology Statistics Theory

Trust snapshot

Quick read

Trust 15 - Baseline

3works

0followers

4topics

4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Open graph Browse works

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

preprint2022arXiv

Distance-based regression analysis for measuring associations

Distance-based regression model, as a nonparametric multivariate method, has been widely used to detect the association between variations in a distance or dissimilarity matrix for outcomes and predictor variables of interest in genetic association studies, genomic analyses, and many other research areas. Based on it, a pseudo-$F$ statistic which partitions the variation in distance matrices is often constructed to achieve the aim. To the best of our knowledge, the statistical properties of the pseudo-$F$ statistic has not yet been well established in the literature. To fill this gap, we study the asymptotic null distribution of the pseudo-$F$ statistic and show that it is asymptotically equivalent to a mixture of chi-squared random variables. Given that the pseudo-$F$ test statistic has unsatisfactory power when the correlations of the response variables are large, we propose a square-root $F$-type test statistic which replaces the similarity matrix with its square root. The asymptotic null distribution of the new test statistic and power of both tests are also investigated. Simulation studies are conducted to validate the asymptotic distributions of the tests and demonstrate that the proposed test has more robust power than the pseudo-$F$ test. Both test statistics are exemplified with a gene expression dataset for a prostate cancer pathway. Keywords: Asymptotic distribution, Chi-squared-type mixture, Nonparametric test, Pseudo-$F$ test, Similarity matrix.

preprint2016arXiv

An efficient and doubly robust empirical likelihood approach for estimating equations with missing data

This paper considers an empirical likelihood inference for parameters defined by general estimating equations, when data are missing at random. The efficiency of existing estimators depends critically on correctly specifying the conditional expectation of the estimating function given the observed components of the random observations. When the conditional expectation is not correctly specified, the efficiency of estimation can be severely compromised even if the propensity function (of missingness) is correctly specified. We propose an efficient estimator which enjoys the double-robustness property and can achieve the semiparametric efficiency bound within the class of the estimating functions that are generated by the estimating function of estimating equations, if both the propensity model and the regression model (of the conditional expectation) are specified correctly. Moreover, if the propensity model is specified correctly but the regression model is misspecified, the proposed estimator still achieves a semiparametric efficiency lower bound within a more general class of estimating functions. Simulation results suggest that the proposed estimators are robust against misspecification of the propensity model or regression model and outperform many existing competitors in the sense of having smaller mean-square errors. Moreover, using our approach for statistical inference requires neither resampling nor kernel smoothing. A real data example is used to illustrate the proposed approach.

preprint2015arXiv

The use of covariates and random effects in evaluating predictive biomarkers under a potential outcome framework

Predictive or treatment selection biomarkers are usually evaluated in a subgroup or regression analysis with focus on the treatment-by-marker interaction. Under a potential outcome framework (Huang, Gilbert and Janes [Biometrics 68 (2012) 687-696]), a predictive biomarker is considered a predictor for a desirable treatment benefit (defined by comparing potential outcomes for different treatments) and evaluated using familiar concepts in prediction and classification. However, the desired treatment benefit is unobservable because each patient can receive only one treatment in a typical study. Huang et al. overcome this problem by assuming monotonicity of potential outcomes, with one treatment dominating the other in all patients. Motivated by an HIV example that appears to violate the monotonicity assumption, we propose a different approach based on covariates and random effects for evaluating predictive biomarkers under the potential outcome framework. Under the proposed approach, the parameters of interest can be identified by assuming conditional independence of potential outcomes given observed covariates, and a sensitivity analysis can be performed by incorporating an unobserved random effect that accounts for any residual dependence. Application of this approach to the motivating example shows that baseline viral load and CD4 cell count are both useful as predictive biomarkers for choosing antiretroviral drugs for treatment-naive patients.